Hostname: page-component-586b7cd67f-g8jcs Total loading time: 0 Render date: 2024-11-28T00:15:17.806Z Has data issue: false hasContentIssue false
  • English
  • Français

Prevalence of and risk factors for methicillin-resistant Staphylococcus aureus skin and soft tissue infection in a Canadian emergency department

Published online by Cambridge University Press:  21 May 2015

Robert Stenstrom ,
Eric Grafstein ,
Marc Romney ,
John Fahimi ,
Devin Harris ,
Garth Hunte ,
Grant Innes  and
Jim Christenson
Robert Stenstrom*
Affiliation:
Department of Emergency Medicine, St. Paul's Hospital, Vancouver, BC The Centre for Health Evaluation and Outcome Sciences, Providence Health Care, Vancouver, BC Department of Emergency Medicine, Faculty of Medicine, University of British Columbia, Vancouver, BC
Eric Grafstein
Affiliation:
Department of Emergency Medicine, St. Paul's Hospital, Vancouver, BC The Centre for Health Evaluation and Outcome Sciences, Providence Health Care, Vancouver, BC Department of Emergency Medicine, Faculty of Medicine, University of British Columbia, Vancouver, BC
Marc Romney
Affiliation:
Department of Microbiology, St. Paul's Hospital, Vancouver, BC Department of Emergency Medicine, Faculty of Medicine, University of British Columbia, Vancouver, BC
John Fahimi
Affiliation:
Department of Emergency Medicine, Faculty of Medicine, University of British Columbia, Vancouver, BC
Devin Harris
Affiliation:
Department of Emergency Medicine, St. Paul's Hospital, Vancouver, BC Department of Microbiology, St. Paul's Hospital, Vancouver, BC Department of Emergency Medicine, Faculty of Medicine, University of British Columbia, Vancouver, BC
Garth Hunte
Affiliation:
Department of Emergency Medicine, St. Paul's Hospital, Vancouver, BC The Centre for Health Evaluation and Outcome Sciences, Providence Health Care, Vancouver, BC Department of Emergency Medicine, Faculty of Medicine, University of British Columbia, Vancouver, BC
Grant Innes
Affiliation:
Department of Emergency Medicine, St. Paul's Hospital, Vancouver, BC Department of Microbiology, St. Paul's Hospital, Vancouver, BC Department of Emergency Medicine, Faculty of Medicine, University of British Columbia, Vancouver, BC
Jim Christenson
Affiliation:
Department of Emergency Medicine, St. Paul's Hospital, Vancouver, BC Department of Microbiology, St. Paul's Hospital, Vancouver, BC Department of Emergency Medicine, Faculty of Medicine, University of British Columbia, Vancouver, BC
*
Emergency Department, St. Paul's Hospital, 1081 Burrard St., Vancouver BC V6Z 1Y6; [email protected]

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Objective:

We sought to estimate the period prevalence of methicillin-resistant Staphylococcus aureus (MRSA) skin and soft tissue infection (SSTI) and evaluate risk factors for MRSA SSTI in an emergency department (ED) population.

Methods:

We carried out a cohort study with a nested case–control design. Patients presenting to our ED with a wound culture and a discharge diagnosis of SSTI between January 2003 and September 2004 were dichotomized as MRSA positive or negative. Fifty patients with MRSA SSTI matched by calendar time to 100 controls with MRSA-negative SSTI had risk factors assessed using multivariate conditional logistic regression.

Results:

Period prevalence of MRSA SSTI was 54.8% (95% confidence interval [CI] 50.2%–59.4%). The monthly period prevalence increased from 21% in January 2003 to 68% in September 2004 (p < 0.01). Risk factors for MRSA SSTI were injection drug use (IDU) (odds ratio [OR] 4.6, 95% CI 1.4–16.1), previous MRSA infection and colonization (OR 6.4, 95% CI 2.1–19.8), antibiotics in 8 weeks preceding index visit (OR 2.6, 95% CI 1.2–8.1), diabetes mellitus (OR 4.1, 95% CI 1.4–12.1), abscess (OR 5.6, 95% CI 1.8–17.1) and admission to hospital in previous 12 months (OR 2.6, 95% CI 1.1–11.2).

Conclusion:

The period prevalence of MRSA SSTI between January 2003 and September 2004 was 54.8% at our institution. There was a marked increase in the monthly period prevalence from the beginning to the end of the study. Risk factors are IDU, previous MRSA infection and colonization, prescriptions for antibiotics in previous 8 weeks and admission to hospital in the preceding 12 months. On the basis of local prevalence and risk factor patterns, emergency physicians should consider MRSA as a causative agent for SSTI.

Keywords

methicillin-resistant Staphylococcus aureus (MRSA)skin and soft tissue infectionprevalenceemergency departmentrisk factorscase–control study
Type
Original Research • Recherche originale
Information
Canadian Journal of Emergency Medicine , Volume 11 , Issue 5 , September 2009 , pp. 430 - 438
Copyright
Copyright © Canadian Association of Emergency Physicians 2009

References

REFERENCES

1.Elston, DM. New and emerging diseases. J Am Acad Dermatol 2005;52:1062–8.Google Scholar
2.Eady, EA, Cove, JH. Staphylococcal resistance revisited: community-acquired methicillin-resistant Staphylococcus aureus — an emerging problem for the management of skin and soft tissue infections. Curr Opin Infect Dis 2003;16:103–24.Google Scholar
3.Nimmo, GR, Pearson, JC, Collignon, PJ, et al Prevalence of MRSA among Staphylococcus aureus isolated from hospital inpatients, 2005: report from the Australian Group for Antimicrobial Resistance. Commun Dis Intell 2007;31:288–96.Google Scholar
4.Miller, LG, Perdreau-Remington, GF, Rieg, G, et al Necrotizing fasciitis caused by community-associated methicillin-resistant Staphylococcus aureus in Los Angeles. N Engl J Med 2005;352:1445–53.Google Scholar
5.Frazee, BW, Salz, TO, Lambert, L, et al Fatal community-associated methicillin-resistant Staphylococcus aureus pneumonia in an immunocompetent young adult. Ann Emerg Med 2005;46:401–4.Google Scholar
6.Chang, WN, Lu, CH, Wu, JJ, et al Staphylococcus aureus meningitis in adults: a clinical comparison of infections caused by methicillin-resistant and methicillin-sensitive strains. Infection 2001;29:245–50.Google Scholar
7.Charlebois, ED, Bangsberg, DR, Moss, NJ, et al Population-based community prevalence of methicillin resistant Staphy-lococcus aureus in the urban poor of San Francisco. Clin Infect Dis 2002;34:425–33.Google Scholar
8.Frazee, BW, Lynn, J, Charlebois, ED, et al High prevalence of methicillin-resistant Staphylococcus aureus in emergency department skin and soft tissue infections. Ann Emerg Med 2005;45:311–20.Google Scholar
9.Purcell, K, Fergie, J, Peterson, MD. Economic impact of the community-acquired methicillin-resistant Staphylococcus aureus epidemic on the Driscoll Children’s Health Plan. Pediatr Infect Dis J 2006;25:178–80.Google Scholar
10.Baillargeon, J, Kelley, MF, Leach, CT, et al Methicillin-resistant Staphylococcus aureus infection in the Texas Prison System. Clin Infect Dis 2004;38:92–5.Google Scholar
11.Lindenmayer, JM, Schoenfeld, S, O’Grady, R, et al Methicillin-resistant Staphylococcus aureus in a high school wrestling team and the surrounding community. Arch Intern Med 1998;158:895–9.Google Scholar
12.Groom, AV, Wolsey, DH, Naimi, TS, et al Community-acquired methicillin-resistant Staphylococcus aureus in a rural American Indian community. JAMA 2001;286:1201–5.Google Scholar
13.Hosmer, DW, LeMeshow, S. Applied logistic regression. Toronto (ON): John Wiley and Sons; 1989.Google Scholar
14.Moran, GJ, Amii, RN, Abrahamian, FM, et al Methicillin-resistant staphylococcus aureus in community-acquired skin infections. Emerg Infect Dis 2005;11:928–30.Google Scholar
15.Moran, GJ, Krishnadasan, A, Gorwitz, J, et al Methicillin-resistant S. aureus infections among patients in the emergency department. N Engl J Med 2006;355:666–74.Google Scholar
16.Bartlett, M, McIntyre, L, Moseley, R, et al Methicillin-resistant S. aureus rates increase 260% in hospitals participating in HIP's international monitoring systems. Centers for Disease Control and National Center for Infectious Diseases Focus 2000;9:4.Google Scholar
17.Genestier, AL, Michallet, MC, Prevost, G, et al Staphylococcus aureus Panton-Valentine leukocidin directly targets mitochondria and induces Bax-independent apoptosis of human neutrophils. J Clin Invest 2005;115:3117–27.Google Scholar
18.Tacconelli, E, De Angelis, G, Cataldo, MA, et al Does antibiotic exposure increase the risk of methicillin-resistant Staphylococcus aureus (MRSA) isolation? A systematic review and meta-analysis. J Antimicrob Chemother 2008;61:26–38.Google Scholar
19.Rajendran, PM, Young, D, Maurer, T, et al Randomized, double-blind, placebo-controlled trial of cephalexin for treatment of uncomplicated skin abscesses in a population at risk for community-acquired methicillin-resistant staphylococcus aureus infection. Antimicrob Agents Chemother 2007;51:4044–8.Google Scholar
20.Chavez-Bueno, S, Bozdogan, B, Katz, K, et al Inducible clindamycin resistance and molecular epidemiologic trends of pediatric community-acquired methicillin resistant Staphylococcus aureus in Dallas, Texas. Antimicrob Agents Chemother 2005;49:2283–8.Google Scholar
21.Stanaway, S, Johnson, D, Moulik, P, et al Methicillin-resistant Staphylococcus aureus (MRSA) isolation from diabetic foot ulcers correlates with nasal MRSA carriage. Diabetes Res Clin Pract 2007;75:47–50.Google Scholar